Biomarker profiles and changes from baseline in trastuzumab (T) refractory HER2-positive inflammatory breast cancer (IBC) that predict decreases in tumor burden from lapatinib (L) monotherapy. SPARC ...
The COVID-19 pandemic has given us an acute, first-hand experience of the risks and morbidities caused by respiratory virus infections. These risks are heightened for people who are immunocompromised, ...
In a small study, Edward Weiss, Ph.D., associate professor of nutrition and dietetics at Saint Louis University, together with SLU graduate students Kym Wroble, R.D. and Morgan Trott, R.D., examined ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback